Ciclosporin aerosol in lung transplantation

Bibliography

• BURCKART GJ, DOWLING R, ZENATI M et al.: Cyclosporine administration by aerosol. J. Clin. Pharmacol. (1989) 29:860.
   Google Scholar
• DECAMP MM: Inhaled cyclosporine – a breath of fresh air? N. Engl. J. Med. (2006) 354:191-193.
   PubMed Web of Science ®Google Scholar
• BURCKART GJ, KEENAN RJ, IACONO AT, GRIFFITH BP: Cyclosporine aerosol in lung transplantation. In: Local immunosuppression of organ transplants, Gruber SA (Ed.), RG Landes Company, Georgetown, USA (1996):131-139.
   Google Scholar
• SCOTT AIR, SHARPLES LD, STEWART S: Bronchiolitis obliterans syndrome: risk factors and therapeutic strategies. Drugs (2005) 65:761-771.
   PubMed Web of Science ®Google Scholar
• IACONO AT, JOHNSON BA, GRGURICH WF et al.: A randomized trial of inhaled cyclosporine in lung-transplant recipients. N. Engl. J. Med. (2006) 354:141-150.
   PubMed Web of Science ®Google Scholar
• MITRUKA SN, WON A, McCURRY KR et al.: In the lung aerosol cyclosporine provides a regional concentration advantage over intramuscular cyclosporine. J. Heart Lung Transplant. (2000) 19:969-675.
   PubMed Web of Science ®Google Scholar
• WHITFORD H, WALTERS EH, LEVVEY B et al.: Addition of inhaled corticosteroids to systemic immunosuppression after lung transplantation: a double-blind, placebo-controlled trial. Transplantation (2002) 73:1793-1799.
   PubMed Web of Science ®Google Scholar
• LIU J: FK506 and cyclosporin, molecular probes for studying intracellular signal transduction. Immunol. Today (1993) 14:290-295 [Erratum in Immunol. Today (1993) 14(8):399].
   PubMedGoogle Scholar
• SCHREIBER SL, CRABTREE GR: The mechanism of action of cyclosporin A and FK506. Immunol. Today (1992) 13:136-142.
   PubMedGoogle Scholar
• BUCHLER M, JOHNSTON A: Seeking optimal prescription of cyclosporine ME. Ther. Drug Monit. (2005) 27:3-6.
   PubMed Web of Science ®Google Scholar
• O’RIORDAN TG, DUNCAN SR, BURCKART GJ, GRIFFITH BP, SMALDONE GC: Production of an aerosol of cyclosporine as a prelude to clinical studies. J. Aerosol Med. (1992) 5:171-177.
   Google Scholar
• O’RIORDAN TG, IACONO A, KEENAN RJ et al.: Delivery and distribution of aerosolized cyclosporine in lung allograft recipients. Am. J. Resp. Crit. Care Med. (1995) 151:516-521.
   PubMed Web of Science ®Google Scholar
• DOWLING RD, ZENATI M, BURCKART GJ et al.: Aerosolized cyclosporine as single-agent immunotherapy in canine lung allografts. Surgery (1990) 108:198-204 (Discussion 204-205).
   PubMed Web of Science ®Google Scholar
• ZENATI M, DUNCAN AJ, BURCKART GJ et al.: Immunosuppression with aerosolized cyclosporine for prevention of lung rejection in a rat model. Eur. J. Cardiothorac. Surg. (1991) 5:266-271 (Discussion 272).
   PubMed Web of Science ®Google Scholar
• KEENAN RJ, DUNCAN AJ, YOUSEM SA et al.: Improved immunosuppression with aerosolized cyclosporine in experimental pulmonary transplantation. Transplantation (1992) 53:20-25.
   PubMed Web of Science ®Google Scholar
• MITRUKA SN, PHAM SM, ZEEVI A et al.: Aerosol cyclosporine prevents acute allograft rejection in experimental lung transplantation. J. Thorac. Cardiovasc. Surg. (1998) 115:28-36 (Discussion 36-37).
   PubMed Web of Science ®Google Scholar
• IACONO A, DAUBER J, KEENAN R et al.: Interleukin 6 and interferon-gamma gene expression in lung transplant recipients with refractory acute cellular rejection: implications for monitoring and inhibition by treatment with aerosolized cyclosporine. Transplantation (1997) 64:263-269.
   PubMed Web of Science ®Google Scholar
• BURCKART GJ, SMALDONE GC, ELDON MA et al.: Lung deposition and pharmacokinetics of cyclosporine after aerosolization in lung transplant patients. Pharm. Res. (2003) 20:252-256.
   PubMed Web of Science ®Google Scholar
• CORCORAN TE, SMALDONE GC, DAUBER JH et al.: Preservation of post-transplant lung function with aerosol cyclosporin. Eur. Respir. J. (2004) 23:378-383.
   PubMed Web of Science ®Google Scholar
• VENKATARAMANAN R, HABUCKY K, BURCKART GJ, PTACHCINSKI RJ: Clinical pharmacokinetics in organ transplant patients. Clin. Pharmacokinet. (1989) 16:134-161.
   PubMed Web of Science ®Google Scholar
• CHRISTIANS U, SEWING KF; Alternative cyclosporine metabolic pathways and toxicity. Clin. Biochem. (1995) 28:547-559.
   PubMed Web of Science ®Google Scholar
• IACONO AT, KEENAN RJ, DUNCAN SR et al.: Aerosolized cyclosporine in lung recipients with refractory chronic rejection. Am. J. Resp. Crit. Care Med. (1996) 153:1451-1455.
   PubMed Web of Science ®Google Scholar
• IACONO AT, CORCORAN TE, GRIFFITH BP et al.: Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans. Eur. Respir. J. (2004) 23:384-390.
   PubMed Web of Science ®Google Scholar
• KEENAN RJ, IACONO A, DAUBER JH et al.: Treatment of refractory acute allograft rejection with aerosolized cyclosporine in lung transplant recipients. J. Thorac. Cardiovasc. Surg. (1997) 113:335-340 (Discussion 340-341).
   PubMed Web of Science ®Google Scholar
• DONNENBERG VS, BURCKART GJ, ZEEVI A et al.: P-glycoprotein activity is decreased in CD4+ but not CD8+ lung allograft-infiltrating T cells during acute cellular rejection. Transplantation (2004) 77:1699-1706.
   PubMed Web of Science ®Google Scholar